toxin neutralization assay
Showing 1 - 25 of 3,412
Anthrax, Anthrax Immunisation Trial in Baltimore (AV7909)
Not yet recruiting
- Anthrax
- Anthrax Immunisation
- AV7909
-
Baltimore, Maryland
- +1 more
Apr 7, 2022
Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Recruiting
- Hematologic Neoplasms
- COVID-19 Vaccines
- S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
- +2 more
-
Vilnius, LithuaniaVilnius University Hospital Santaros Klinikos
Dec 27, 2021
Biomarkers of Trained Immunity Following MMR Vaccination
Completed
- Covid19
- Heterologous stimuli
- Neutralization assay
-
Saint Louis, MissouriWashington University School of Medicine
Nov 24, 2021
Vaccination Trial in Nanjing (Sabin-IPV and DTaP, Sabin-IPV, DTaP)
Completed
- Vaccination
- Sabin-IPV and DTaP
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 5, 2022
Anthrax Trial in Yeongeon-dong (GC1109 or Placebo of GC1109)
Completed
- Anthrax
- GC1109 or Placebo of GC1109
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 2, 2023
Clostridium Difficile Infection Trial in Canada, United States (Comparison between GenePOC PCR and Reference Method)
Completed
- Clostridium Difficile Infection
- Comparison between GenePOC PCR and Reference Method
-
Indianapolis, Indiana
- +6 more
Apr 29, 2021
Anthrax Trial in United States (AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL))
Not yet recruiting
- Anthrax
- AV7909 Full Dose (0.5 mL)
- AV7909 Half Dose (0.25 mL)
-
Hickory, North Carolina
- +6 more
Aug 10, 2023
Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)
Not yet recruiting
- Healthy Volunteers
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Diseases Research, Banglades
Aug 3, 2023
Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile
Completed
- Clostridium Infections
- C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
- +2 more
-
Gent, BelgiumGSK Investigational Site
Jun 9, 2022
SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood
Completed
- SARS-CoV2 Infection
-
Starkville, Mississippi
- +4 more
Aug 8, 2022
Covid19 Trial in Hong Kong (Tozinameran, CoronaVac, CoronaVac, intradermal)
Active, not recruiting
- Covid19
- Tozinameran
- +2 more
-
Hong Kong, Hong Kong, ChinaQueen Mary Hospital
Jul 14, 2022
Polio Trial in Antwerpen (IMOVAX Inactivated Poliomyelitis Vaccine (IPV), dmLT (adjuvant), Bivalent oral polio vaccine (bOPV))
Completed
- Polio
- Inactivated Poliomyelitis Vaccine (IPV)
- +2 more
-
Antwerpen, Wilrijk, BelgiumUniversity of Antwerpen
Apr 5, 2022
Temporomandibular Disorders Trial (Botulinum toxin type A, Isotonic saline 0,9%)
Not yet recruiting
- Temporomandibular Disorders
- Botulinum toxin type A
- Isotonic saline 0,9%
- (no location specified)
Jan 30, 2023
Clostridium Difficile Infection Trial in Worldwide (C. difficile Toxoid Vaccine, Placebo: 0.9% normal saline)
Terminated
- Clostridium Difficile Infection
- C. difficile Toxoid Vaccine
- Placebo: 0.9% normal saline
-
Huntsville, Alabama
- +334 more
Mar 21, 2022
Second Booster Dose of Vaccine Against COVID-19 in Elderly
Not yet recruiting
- COVID-19
- +2 more
- ChAdOx1 nCoV-19 or Comirnaty or Janssen COVID-19 Vaccine
-
Vitória, Espírito Santo, BrazilValéria Valim
Mar 15, 2022
Chronic Lymphocytic Leukemia, COVID-19 Trial in Toronto (EVUSHELD)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19
- EVUSHELD
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Cente
Jul 18, 2022
COVID-19 Trial in Beijing (SA55 nasal spray)
Recruiting
- COVID-19
- SA55 nasal spray
-
Beijing, Chaoyang, ChinaBeijing Ditan Hospital Capital Medical University
Sep 15, 2023
Evaluation Study of DPP® Typhoid Assay
Recruiting
- Typhoid Fever
- Typhoid DPP assay
-
Karachi, PakistanAga Khan University
Oct 11, 2022
Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,
Recruiting
- Sarcoidosis
- +2 more
- Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
-
Chicago, IllinoisNorthwestern Medicine
Dec 6, 2021
Healthy Volunteers Trial in Salt Lake City (NasoShield, Placebo)
Completed
- Healthy Volunteers
- NasoShield
- Placebo
-
Salt Lake City, UtahJBR Clinical Research
May 12, 2021
Tick Borne Encephalitis Trial in Vienna (TBE virus vaccine)
Completed
- Tick Borne Encephalitis
- TBE virus vaccine
-
Vienna, AustriaMedical University of Vienna, Department of Medicine I, Division
Jan 27, 2022
Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Tagraxofusp-erzs
-
Los Angeles, California
- +1 more
Jan 31, 2023
Post Stroke Spastic Hemiplegia Trial in Ioannina (Botulinum toxin, gait analysis)
Recruiting
- Post Stroke Spastic Hemiplegia
- Botulinum toxin
- gait analysis
-
Ioannina, GreeceDepartment of Physical Medicine and Rehabilitation, University H
Sep 27, 2021
Involuntary Movement Disorders
Recruiting
- Movement Disorders
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Stroke, Hemiplegia, Spastic, Muscle Spasticity Trial in Seoul (Extracorporeal shock wave therapy, Botulinum toxin treatment)
Completed
- Stroke
- +2 more
- Extracorporeal shock wave therapy
- Botulinum toxin treatment
-
Seoul, Korea, Republic ofKorea university guro hospital
May 25, 2023